|
CA889876A
|
|
Purification of glyburide
|
|
CA891529A
|
|
Preparation of n-phenethyl-5-chloro-2-methoxybenzamide
|
|
CA876138A
|
|
Preparation of p-(2-(5-chloro-2-methoxy-benzamido)ethyl)-benzene sulfonamide and intermediates thereof
|
|
CA915702A
|
|
Preparation of 1-benzene-sulfonyl-3-hydrocarbylureas and derivatives
|
|
GB1152959A
|
|
Coating
|
|
US3448141A
|
|
Unsymmetrical derivatives of djenkolic acid
|
|
US3448142A
|
|
Unsymmetrical djenkolic acid derivatives
|
|
US3448143A
|
|
Derivatives of djenkolic acid
|
|
GB1096005A
|
|
Substituted biurets
|
|
US3548053A
|
|
Interferon production
|
|
US3407193A
|
|
Substituted biurets
|
|
US3350396A
|
|
Quaternary ammonium salts of morpholinoethyl 3, 4, 5-trimethoxybenzoate
|
|
US3251737A
|
|
Methods for inhibiting gastric secretions with substituted biurets
|
|
GB957992A
|
|
Quaternized aminoalkyl esters of 3,4,5-trimethoxybenzoic acid
|
|
GB938348A
|
|
Esters of di-tertiary-butylnaphthalene-4-sulfonic acids
|
|
GB909365A
|
|
Orally ingestible solid penicillin compositions
|
|
GB891445A
|
|
Pharmaceutical compositions comprising sulphonamido-thiadiazole derivatives
|
|
GB877927A
|
|
Therapeutic compositions containing isoniazid
|
|
US3137620A
|
|
2-p-methoxybenzenesulfonamide-5-isobutyl-1, 3, 4-thiadiazole in the oral treatment of acne
|
|
GB901674A
|
|
Therapeutic compositions containing glucuronylation inhibitors
|
